Contact information

More contact information

The Nomination Committee's proposal regarding the Board of Humana for the 2021 AGM

2021-01-18 09:00

Ahead of the Annual General Meeting 2021 the Nomination Committee of Humana AB proposes that the Board be composed of six directors elected at the Annual General Meeting, with no alternates, for the period until the next Annual General Meeting.

Download PDF

The Nomination Committee proposes re-election of Karita Bekkemellem, Kirsi Komi, Monica Lingegård, Sören Mellstig, Anders Nyberg and Fredrik Strömholm as directors. The director Magdalena Gerger has declared that she is not available for re-election. The Nomination Committee proposes that Sören Mellstig be re-elected Chairman of the Board.

The Nomination Committee prior to the 2021 AGM comprises the following members: Fredrik Strömholm, appointed by Impilo Care AB (Chair of the Nomination Committee), Alexander Kopp, appointed by Incentive AS, Mats Hellström, appointed by Nordea Funds Ltd, Simone Hirschvogl, appointed by SEB Investment Management AB and Sören Mellstig, Humana’s Chairman of the Board.

The Nomination Committee’s other proposals for the AGM on May 11, 2021 and the statement on the proposed Board will be available on the company’s website in connection with the publishing of the notice convening the AGM.

For more information, please contact:

Fredrik Strömholm, Director of the Board and Chair of the Nomination Committee, +46 76 115 10 65,
Anna Sönne, Head of Investor Relations, +46 70 601 48 53,

Humana is a leading Nordic care company providing services within individual and family care, personal assistance, elderly care and special service housing in accordance with LSS. Humana has 15,000 employees in Sweden, Norway, Finland and Denmark providing care for 9,000 individuals and working to achieve the vision “Everyone is entitled to a good life”. In 2019, Humana’s operating revenue was SEK 7,467m. Humana is listed on Nasdaq Stockholm and the company’s headquarters are located in Stockholm. Read more about Humana on: